Ozempic (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025
Ozempic® improved maximum walking distance by 13% vs placebo in adults with…
Venus Williams Invests in WeWard App to Promote a Healthier World Through Walking
Tennis champion and entrepreneur Venus Williams joins walking app WeWard as an investor…
